148 related articles for article (PubMed ID: 25205462)
1. Metal based imaging probes of DO3A-Act-Met for LAT1 mediated methionine specific tumors: synthesis and preclinical evaluation.
Kadiyala KG; Datta A; Tanwar J; Adhikari A; Kumar BS; Chuttani K; Thirumal M; Mishra AK
Pharm Res; 2015 Mar; 32(3):955-67. PubMed ID: 25205462
[TBL] [Abstract][Full Text] [Related]
2. LAT1 targeted delivery of methionine based imaging probe derived from M(III) metal ions for early diagnosis of proliferating tumours using molecular imaging modalities.
Hazari PP; Prakash S; Meena VK; Jaswal A; Khurana H; Mishra SK; Bhonsle HK; Singh L; Mishra AK
Curr Cancer Drug Targets; 2015; 14(9):817-31. PubMed ID: 25329672
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of specific SPECT-radiopharmaceutical for tumor imaging based on methionine: 99mTc-DTPA-bis(methionine).
Hazari PP; Shukla G; Goel V; Chuttani K; Kumar N; Sharma R; Mishra AK
Bioconjug Chem; 2010 Feb; 21(2):229-39. PubMed ID: 20108938
[TBL] [Abstract][Full Text] [Related]
4.
Watabe T; Ikeda H; Nagamori S; Wiriyasermkul P; Tanaka Y; Naka S; Kanai Y; Hagiwara K; Aoki M; Shimosegawa E; Kanai Y; Hatazawa J
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):321-331. PubMed ID: 27550420
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, conjugation and relaxation studies of gadolinium(III)-4-benzothiazol-2-yl-phenylamine as a potential brain specific MR contrast agent.
Saini N; Varshney R; Tiwari AK; Kaul A; Allard M; Ishar MP; Mishra AK
Dalton Trans; 2013 Apr; 42(14):4994-5003. PubMed ID: 23389482
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of (111)In-labeled macrocyclic chelator-amino acid derivatives for cancer imaging.
Lee JJ; Shetty D; Lee YS; Kim SE; Kim YJ; Hong MK; Son JY; Jeong JM
Nucl Med Biol; 2012 Apr; 39(3):325-33. PubMed ID: 22136890
[TBL] [Abstract][Full Text] [Related]
7. Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.
Okubo S; Zhen HN; Kawai N; Nishiyama Y; Haba R; Tamiya T
J Neurooncol; 2010 Sep; 99(2):217-25. PubMed ID: 20091333
[TBL] [Abstract][Full Text] [Related]
8. Tumor targeting using anti-epidermal growth factor receptor (ior egf/r3) immunoconjugate with a tetraaza macrocyclic agent (DO3A-EA).
Mishra G; Panwar P; Mishra AK
Mol Imaging; 2012; 11(5):408-16. PubMed ID: 22954185
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of choline based SPECT imaging agent: Ga(III)-DO3A-EA-Choline.
Uppal JK; Hazari PP; Raunak ; Chuttani K; Allard M; Kaushik NK; Mishra AK
Org Biomol Chem; 2011 Mar; 9(5):1591-9. PubMed ID: 21246138
[TBL] [Abstract][Full Text] [Related]
10. [(68) Ga]-HP-DO3A-nitroimidazole: a promising agent for PET detection of tumor hypoxia.
Wu Y; Hao G; Ramezani S; Saha D; Zhao D; Sun X; Sherry AD
Contrast Media Mol Imaging; 2015; 10(6):465-72. PubMed ID: 26122548
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a novel L-methyl-methionine-ICG-Der-02 fluorescent probe for in vivo near infrared imaging of tumors.
Mahounga DM; Shan L; Jie C; Du C; Wan S; Gu Y
Mol Imaging Biol; 2012 Dec; 14(6):699-707. PubMed ID: 22552743
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of DO3A-Act-AQ: a polyazamacrocyclic monomeric anthraquinone derivative as a theranostic agent.
Adhikari A; Datta A; Adhikari M; Chauhan K; Chuttani K; Saw S; Shukla A; Mishra AK
Mol Pharm; 2014 Feb; 11(2):445-56. PubMed ID: 24359093
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors.
Mishra G; Hazari PP; Kumar N; Mishra AK
J Drug Target; 2011 Nov; 19(9):761-9. PubMed ID: 21425922
[TBL] [Abstract][Full Text] [Related]
15. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
[TBL] [Abstract][Full Text] [Related]
16. 5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET.
Krämer SD; Mu L; Müller A; Keller C; Kuznetsova OF; Schweinsberg C; Franck D; Müller C; Ross TL; Schibli R; Ametamey SM
J Nucl Med; 2012 Mar; 53(3):434-42. PubMed ID: 22331220
[TBL] [Abstract][Full Text] [Related]
17. [⁶⁸Ga]NS₃-RGD and [⁶⁸Ga] Oxo-DO3A-RGD for imaging α(v)β₃ integrin expression: synthesis, evaluation, and comparison.
Knetsch PA; Petrik M; Rangger C; Seidel G; Pietzsch HJ; Virgolini I; Decristoforo C; Haubner R
Nucl Med Biol; 2013 Jan; 40(1):65-72. PubMed ID: 23102540
[TBL] [Abstract][Full Text] [Related]
18.
Nozaki S; Nakatani Y; Mawatari A; Shibata N; Hume WE; Hayashinaka E; Wada Y; Doi H; Watanabe Y
Sci Rep; 2019 Oct; 9(1):15718. PubMed ID: 31673030
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of
Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
[TBL] [Abstract][Full Text] [Related]
20. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
